Cite

HARVARD Citation

    Getz, K. et al. (2022). Cytarabine dose reduction in patients with low‐risk acute myeloid leukemia: A report from the Children's Oncology Group. Pediatric blood & cancer. 69 (1), p. n/a. [Online]. 
  
Back to record